BOM:543220 (India)
Â
Ordinary Shares
â‚ą
1,279.6
+4.4 (+0.35%)
Jul 1
Business Description
Max Healthcare Institute Ltd
ISIN : INE027H01010
Share Class Description:
BOM:543220: Ordinary SharesCompare
Compare
Traded in other countries / regions
543220.India IPO Date
2020-08-21Description
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | 1.56 | |||||
| Interest Coverage | 9.03 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 13.54 | |||||
| Beneish M-Score | -2.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.5 | |||||
| 3-Year EBITDA Growth Rate | 22.2 | |||||
| 3-Year EPS without NRI Growth Rate | 21.1 | |||||
| 3-Year FCF Growth Rate | 37.8 | |||||
| 3-Year Book Growth Rate | 14.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 33.45 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 28.08 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.48 | |||||
| 9-Day RSI | 68.65 | |||||
| 14-Day RSI | 64.97 | |||||
| 3-1 Month Momentum % | 3.83 | |||||
| 6-1 Month Momentum % | -1.28 | |||||
| 12-1 Month Momentum % | 17.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.88 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.41 | |||||
| Days Inventory | 23.02 | |||||
| Days Sales Outstanding | 29.06 | |||||
| Days Payable | 183.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.12 | |||||
| Dividend Payout Ratio | 0.13 | |||||
| Forward Dividend Yield % | 0.12 | |||||
| 5-Year Yield-on-Cost % | 0.12 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -0.93 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.99 | |||||
| Operating Margin % | 21.19 | |||||
| Net Margin % | 15.31 | |||||
| EBITDA Margin % | 27.47 | |||||
| FCF Margin % | 7.03 | |||||
| ROE % | 12.14 | |||||
| ROA % | 8 | |||||
| ROIC % | 9.18 | |||||
| 3-Year ROIIC % | 7.86 | |||||
| ROC (Joel Greenblatt) % | 32.08 | |||||
| ROCE % | 13.2 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 115.82 | |||||
| Forward PE Ratio | 66.49 | |||||
| PE Ratio without NRI | 110.01 | |||||
| Shiller PE Ratio | 319.39 | |||||
| Price-to-Owner-Earnings | 130.87 | |||||
| PEG Ratio | 2.11 | |||||
| PS Ratio | 17.73 | |||||
| PB Ratio | 13.21 | |||||
| Price-to-Tangible-Book | 37.18 | |||||
| Price-to-Free-Cash-Flow | 252.36 | |||||
| Price-to-Operating-Cash-Flow | 85.39 | |||||
| EV-to-EBIT | 80.61 | |||||
| EV-to-EBITDA | 65.6 | |||||
| EV-to-Revenue | 18.02 | |||||
| EV-to-FCF | 255.66 | |||||
| Price-to-GF-Value | 1.21 | |||||
| Price-to-Projected-FCF | 10.79 | |||||
| Price-to-Graham-Number | 13.51 | |||||
| Earnings Yield (Greenblatt) % | 1.24 | |||||
| FCF Yield % | 0.4 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers